SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-21-000092
Filing Date
2021-11-19
Accepted
2021-11-19 13:01:14
Documents
14
Period of Report
2021-11-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K DATED NOVEMBER 16, 2021 RE AUTHORIZED SHARE REDUCTION form8kdtd111621.htm   iXBRL 8-K 23178
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION ex3_1.htm EX-3.1 569
6 coa.jpg GRAPHIC 636112
  Complete submission text file 0001021771-21-000092.txt   1038098

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brtx-20211116.xsd EX-101.SCH 3941
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20211116_lab.xml EX-101.LAB 23289
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20211116_pre.xml EX-101.PRE 16562
7 EXTRACTED XBRL INSTANCE DOCUMENT form8kdtd111621_htm.xml XML 4219
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 211427597
SIC: 8090 Services-Misc Health & Allied Services, NEC